Cencora Global Consulting Services acquires stake in Neohealthhub Limited
Published
Neohealthhub Limited is a pharmaceutical and healthcare service consultancy based in Nottingham. Founded in 2020, the company provides integrated growth solutions including market access, data analysis, and capability development for global healthcare and pharmaceutical brands. It focuses on helping clients identify and succeed in critical market moments throughout the brand lifecycle.
The company's latest confirmation statement, covering the period up to 3 June 2026, shows that Cencora Global Consulting Services UK Holding Limited has joined the cap table as a shareholder. The entity now holds 115,240 shares in total, comprised of 115,200 B Ordinary shares and 40 A Ordinary shares.
This change follows the full exit of Pharmalex UK Holding Limited from the company's share register. Pharmalex UK Holding Limited previously held the identical stake of 115,240 shares before the transfer occurred. The filing, which was processed at Companies House on 19 June 2026, confirms that Pharmalex UK Holding Limited no longer maintains a holding in the consultancy.
The transition of the 115,240 shares to Cencora Global Consulting Services UK Holding Limited is the primary update to the ownership structure during this reporting window. No other new investors or departures were listed in the documentation for this period.
Shareholder data
Source: Companies House confirmation statement (CS01) — period to , filed .
Changes in this confirmation statement
| Type | Shareholder | Shares | Change | Share classes |
|---|---|---|---|---|
| Exited | PHARMALEX UK HOLDING LIMITED | 115,240 | — | B ORDINARY 115,200 A ORDINARY 40 |
| New shareholder | CENCORA GLOBAL CONSULTING SERVICES UK HOLDING LIMITED | 115,240 | — | B ORDINARY 115,200 A ORDINARY 40 |
Current shareholders (1)
| Shareholder | Total shares | Share classes |
|---|---|---|
| CENCORA GLOBAL CONSULTING SERVICES UK HOLDING LIMITED | 115,240 | A ORDINARY 40 B ORDINARY 115,200 |
Contact the editorial team at [email protected]